Search Results 781-790 of 14789 for anti-TNF drugs

  1. Lefamulin (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. A Study of the Safety and Drug/Body Interactions of LAM-002A for Patients with Non-Hodgkin's Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability, drug/body interactions, and preliminary activity of LAM-002A for the treatment of patients ...

  3. Brexucabtagene Autoleucel (Intravenous Route) Description and Brand Names - Mayo Clinic

    Before you begin treatment, talk to your doctor about the benefits of this medicine as well as the possible risks of receiving it. This medicine is available ...

  4. Omadacycline (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Mayo Clinic Q and A: Drug interactions with foods and drinks

    DEAR MAYO CLINIC: I've heard I should avoid certain foods like grapefruit and broccoli, as well as alcoholic beverages, when taking certain medications.

  6. Technetium Tc 99m Mertiatide (Injection Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Efineptakin alfa (NT-I7) Plus Pembrolizumab for the Treatment of Recurrent Glioblastoma - Mayo Clinic

    Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent. Participating Mayo Clinic locations. Study statuses change often. Please contact ...

  8. Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS - Mayo Clinic

    ... medications for Crohn's disease therapy -Prior treatment failure or intolerance with at least one Anti Tumor Necrosis Factor-Alpha Therapy (anti-TNF α) agent.

  9. Overview - Rheumatology - Mayo Clinic Research

    Vasculitis — giant cell arteritis, anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and all other forms of vasculitis. Systemic autoimmune ...

  10. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Subject who received non-steroidal anti-inflammatory drugs (NSAIDs) (except topical NSAIDs and the use of low dose aspirin for cardiovascular [CV] protection) ...